Aptose Biosciences Inc. - Common Shares (APTO)

CUSIP: 03835T309

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Shares
Shares outstanding
2,587,950
Total 13F shares
977,602
Share change
-131,033
Total reported value
$1,623,107
Price per share
$1.66
Number of holders
20
Value change
-$345,174
Number of buys
4
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 03835T309?
CUSIP 03835T309 identifies APTO - Aptose Biosciences Inc. - Common Shares in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q1 2024

As of 31 Mar 2024, Aptose Biosciences Inc. - Common Shares (APTO) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 977,602 shares. The largest 10 holders included DRW Securities, LLC, Sigma Planning Corp, Nantahala Capital Management, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, Cetera Investment Advisers, Texas Capital Bank Wealth Management Services Inc, PDS Planning, Inc, US BANCORP \DE\, and Gleason Group, Inc.. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.